Consolidated Statements of Operations (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Income Statement [Abstract]
Sales	$ 2,028,897	$ 3,510,042
Cost of sales	(1,436,814)	(2,064,881)
Gross profit	592,083	1,445,161
Operating Expenses:
General and adminstrative expenses	1,416,918	1,593,369
Selling expenses	175,261	221,561
Research and development expenses	19,831	221,614
Total Operating Expenses	1,612,010	2,036,544
Loss from operations	(1,019,927)	(591,383)
Interest expense	(474,938)	(3,472,845)
Change in fair market value of derivative liability	19,102	418,192
Equity in loss of unconsolidated subsidiary
Loss before provision for income taxes	(1,475,763)	(3,646,036)
Provision for income taxes
Net loss	$ (1,475,763)	$ (3,646,036)
Loss per common share	$ (0.02)	$ (0.06)
Basic and diluted weighted average common share outstanding	63,142,969	56,366,331